semaglutide for binge eating disorder New hope and bulimia: GLP-1 drugs could be the key The rapid rise of GLP-1

Effects of BTR signaling on gut hormone secretion An increasing number of studies in both preclinical and clinical models have evaluated the effects of BTR agonists on ghrelin, CCK, GLP-1, and PYY secretion, although the specificity of bitter compounds for different T2Rs is poorly defined and the function of intestinal BTR sensing in either obesity or type 2 diabetes has not been thoroughly investigated

This makes retatrutide a promising alternative to other treatments like semaglutide (Wegovy) and tirzepatide (Zepbound), both of which are FDA-approved and available at Klinic

This review also summarizes and highlights current limitations in targeting the Th17/Treg balance for AR treatment and suggests future research directions, aiming to provide new insights and strategies for clinical management (Fig

Secondary deficiency